Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial

Por Ray, Michael E., Bae, Kyounghwa, Hussain, Maha H. A., Hanks, Gerald E., Shipley, William U., Sandler, Howard M.
Publicado em 2009

Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

Por Flaig, Thomas W., Plets, Melissa, Hussain, Maha H. A., Agarwal, Neeraj, Mitsiades, Nicholas, Deshpande, Hari A., Vaishampayan, Ulka N., Thompson, Ian M.
Publicado no JAMA Oncol (2017)

A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)

Por deVere White, Ralph W., Lara, Primo N., Goldman, Bryan, Tangen, Cathy M., Smith, David C., Wood, David P., Hussain, Maha H. A., Crawford, E. David
Publicado em 2009

Cooperative group trials – Southwest Oncology Group (SWOG) innovations in advanced prostate cancer

Por Dorff, Tanya B., Tangen, Cathy M., Crawford, E. David, Petrylak, Daniel P., Higano, Celestia S., Raghavan, Derek, Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian M., Hussain, Maha H.A.
Publicado em 2009

Antiandrogen Withdrawal in Castrate-refractory Prostate Cancer: A Southwest Oncology Group Trial (SWOG 9426)

Por Sartor, A. Oliver, Tangen, Catherine M., Hussain, Maha H. A., Eisenberger, Mario A., Parab, Minoti, Fontana, Joseph A., Chapman, Robert A., Mills, Glenn M., Raghavan, Derek, Crawford, E. David
Publicado em 2008

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma o...

Por Smith, David C., Tangen, Cathy M., Hussain, Maha H.A., Van Veldhuizen, Peter J., Harrer, Grant W., Stuart, Robert K., Mills, Glenn M., Vogelzang, Nicholas J., Thompson, Ian M.
Publicado em 2011

Inflammatory Bowel Disease and the Risk of Prostate Cancer

Por Burns, Jacob A., Weiner, Adam B., Catalona, William J., Li, Eric V., Schaeffer, Edward M., Hanauer, Stephen B., Strong, Scott, Burns, James, Hussain, Maha H.A., Kundu, Shilajit D.
Publicado no Eur Urol (2018)

Bladder Cancer: Narrowing the Gap Between Evidence and Practice

Por Hussain, Maha H.A., Wood, David P., Bajorin, Dean F., Bochner, Bernard H., Dreicer, Robert, Lamm, Donald L., O'Donnell, Michael A., Siefker-Radtke, Arlene O., Theodorescu, Dan, Dinney, Colin P.
Publicado no J Clin Oncol (2009)

Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 & S9346)

Por Tangen, Catherine M., Hussain, Maha H.A., Higano, Celestia S., Eisenberger, Mario A., Small, Eric J., Wilding, George, Donnelly, Bryan J., Schelhammer, Paul F., Crawford, E. David, Vogelzang, Nicholas J., Powell, Isaac J., Thompson, Ian M.
Publicado em 2012

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Por Dorff, Tanya B., Flaig, Thomas W., Tangen, Catherine M., Hussain, Maha H.A., Swanson, Gregory P., Wood, David P., Sakr, Wael A., Dawson, Nancy A., Haas, Naomi B., Crawford, E. David, Vogelzang, Nicholas J., Thompson, Ian M., Glode, L. Michael
Publicado em 2011

Validation of the association of RECIST changes with survival in men with metastatic castration resistant prostate cancer treated on SWOG study S0421

Por Sonpavde, Guru, Pond, Gregory R., Plets, Melissa, Tangen, Catherine M., Hussain, Maha H.A., Lara, Primo N., Goldkorn, Amir, Garzotto, Mark G., Mack, Philip C., Higano, Celestia S., Vogelzang, Nicholas J., Thompson, Ian M., Twardowski, Przemyslaw W., Van Veldhuizen, Peter J., Agarwal, Neeraj, Carducci, Michael A., Monk, J. Paul, Quinn, David I.
Publicado no Clin Genitourin Cancer (2017)

Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216)

Por Goldkorn, Amir, Tangen, Catherine, Plets, Melissa, Morrison, Gareth J., Cunha, Alexander, Xu, Tong, Pinski, Jacek K., Ingles, Sue A., Triche, Timothy, Harzstark, Andrea L., Kohli, Manish, MacVicar, Gary R., Vaena, Daniel A., Crispino, Anthony W., McConkey, David J., Lara, Primo N., Hussain, Maha H. A., Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian Murchie, Agarwal, Neeraj
Publicado no Clin Cancer Res (2021)